Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Comprendre en 2 minutes

Understanding in 2 minutes: the leukodystrophy

Comprendre en 2 minutes les leucodystrophies

Professor Fanny MOCHEL, Neurologist at AP-HP and researcher at Paris Brain Institute (Sorbonne University / AP-HP), explains the causes, symptoms and treatments of leukodystrophy.

News that might interest you

Lésions d’un patient à l’inclusion dans le protocole (M0) disparues après 2 ans de traitement à la Leriglitazone (M24)
The dual effect of leriglitazone in X-linked Adrenoleukodystrophy (X-ALD)
In 2023, the team led by Professor Fanny Mochel (AP-HP, Sorbonne University), a Paris brain Institute researcher, showed that daily dose of leriglitazone slow down the progression of myelopathy in patients with X-linked adrenoleukodystrophy, and...
06.28.2024 Research, science & health
Leucodystrophie
New gene therapy for metachromatic leukodystrophy proves effective in mice
Metachromatic leukodystrophy is a rare genetic disorder that mainly affects young children and results in severe neurological symptoms accompanied by a loss of motor and intellectual capacities. At Paris Brain Institute, Françoise Piguet and her...
04.22.2024 Research, science & health
See all our news